BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma.
F
F
Brito-Babapulle
R
R
Arya
T
T
Griffiths
A
A
Pagliuca
G J
GJ
Mufti
D000971:Antineoplastic Combined Chemotherapy Protocols; D002330:Carmustine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged
D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D008558:Melphalan; D002330:Carmustine